asialo-gm1-ganglioside and Cryptococcosis

asialo-gm1-ganglioside has been researched along with Cryptococcosis* in 2 studies

Other Studies

2 other study(ies) available for asialo-gm1-ganglioside and Cryptococcosis

ArticleYear
A T cell-independent protective host response against Cryptococcus neoformans expressed at the primary site of infection in the lung.
    Infection and immunity, 1993, Volume: 61, Issue:12

    T cell-independent host resistance expressed against a primary lung infection with Cryptococcus neoformans was investigated. Following intratracheal inoculation of the yeast, BALB/cBy scid/scid mice or CD4+ plus CD8+ T cell-depleted BALB/cBy mice developed a primary lung infection that remained stable for several weeks before progressing and disseminating to kill the host. By contrast, normal BALB/cBy hosts resolved the infection after 4 to 8 weeks. Thy+ CD4- CD8- cells were found to accumulate in the pulmonary alveoli of infected scid/scid or normal mice. Depletion of these cells caused the infection to progress more rapidly and resulted 4 weeks later in a 30- to 70-fold increase in yeast numbers in the lungs and dissemination to extrapulmonary sites. Cytofluorometric studies revealed that the Thy+ CD4- CD8- cells responsible were negative for the CD3 T cell marker. A small percentage of these Thy+ CD3- cells expressed asialo-Gm1, but treatment with asialo-Gm1 antibody did not have the same infection-enhancing effect as Thy-1 monoclonal antibody treatment. Further experiments revealed that Thy-1 monoclonal antibody treatment had no effect on the establishment of infectious foci in the brain or liver following intravenous inoculation of the yeast. The data point to the existence of an early resistance mechanism for which Thy+ CD3- CD4- CD8- cells are essential. This mechanism of host defense, while insufficient for complete protection, may be capable of delaying the development of cryptococcal meningoencephalitis by restricting the growth of the yeast at primary sites of infection in the lungs, even in immunodeficient mice.

    Topics: Animals; Antigens, Surface; CD4 Antigens; CD8 Antigens; Cryptococcosis; G(M1) Ganglioside; Immunity, Cellular; Killer Cells, Natural; Lung; Lung Diseases, Fungal; Lymphocyte Depletion; Membrane Glycoproteins; Meningitis, Cryptococcal; Mice; Mice, Inbred BALB C; Mice, SCID; Opportunistic Infections; T-Lymphocyte Subsets; Thy-1 Antigens

1993
Role of natural killer cells in resistance to Cryptococcus neoformans infections in mice.
    The American journal of pathology, 1987, Volume: 128, Issue:2

    Previous studies have suggested a possible role for natural killer (NK) cells in resistance to some fungal infections, including Cryptococcus neoformans infections. The role of NK cells in early clearance of C neoformans from tissues and in long-term survival was studied in mice following intravenous inoculations of the organism. Mice treated with anti-asialo GM1 antiserum to temporarily reduce NK activity demonstrated an increase in colony-forming units (CFU) of C neoformans in the lung 24 hours after an intravenous inoculation of the organism. CFU in liver, spleen, kidney, and brain were not different in anti-asialo GM1 antiserum-treated versus control mice. An NK-specific reagent, anti-NK 1.1 monoclonal antibody, was used to deplete mice of NK cells in vivo for at least 14 days without affecting other natural defenses. The number of C neoformans retained in the lungs 24 hours after inoculation of the organism was significantly greater in NK cell-depleted mice than in controls, although CFU in other organs were unaffected. Following the intravenous inoculation of C neoformans, the survival of anti-NK 1.1-treated mice was not different from control mice. The effect of NK cell activity on resistance to C neoformans was also determined after an intratracheal inoculation of the organism. Mice pretreated with anti-NK 1.1 demonstrated no increases in CFU in the lungs, spleen, or brain as compared with controls. These data indicate that NK cells can play a role in vivo in early resistance against C neoformans if the organism is delivered via the intravenous route. However, NK cells do not play a role in either determining survival after an intravenous inoculation nor in resistance during an infection acquired via the respiratory tract.

    Topics: Animals; Antibodies, Monoclonal; Cryptococcosis; G(M1) Ganglioside; Glycosphingolipids; Immune Sera; Killer Cells, Natural; Lung; Mice; Mice, Inbred C57BL; Trachea

1987